Jin Hyoung Kang

The transcriptional landscape and mutational profile of lung adenocarcinoma

Jeong‐Sun Seo, Young Seok Ju, Won‐Chul Lee et al. · Genome Research · 2012 · 587 citations · Full text

A transforming <i>KIF5B</i> and <i>RET</i> gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing

Young Seok Ju, Won‐Chul Lee, Jong-Yeon Shin et al. · Genome Research · 2011 · 464 citations · Full text

Engineering, Genetics, Lung Adenocarcinoma +16

Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04

Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim et al. · Journal of Clinical Oncology · 2015 · 251 citations · Full text

First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer

Keunchil Park, Chong‐Jen Yu, Sang-We Kim et al. · JAMA Oncology · 2015 · 225 citations

Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

Ying Cheng, Haruyasu Murakami, Pan‐Chyr Yang et al. · Journal of Clinical Oncology · 2016 · 185 citations